MedPath

PREMISE: a surgical trial of minimally invasive treatments of prostate obstruction of the bladder

Not Applicable
Conditions
Minimally invasive surgical treatments for bladder outlet obstruction due to enlarged prostate
Surgery
Registration Number
ISRCTN50571778
Lead Sponsor
ewcastle upon Tyne Hospitals NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
Male
Target Recruitment
536
Inclusion Criteria

1. Men aged 50 years or over
2. Prostate volume up to 80cc (measured by ultrasound or cross-sectional scan)
3. Eligible for surgery for presumed Bladder Outlet Obstruction with an NHS setting
4. Willing and able to comply with trial procedures, visit schedules, trial restrictions and requirements.
5. Willing and able to provide informed consent.

Exclusion Criteria

1. Any known or suspected prostate cancer treated or untreated; (If known) PSA > = 0.15
2. Known or suspected neuropathic bladder dysfunction
3. Any previous minimally invasive or surgical treatment to the prostate or bladder outlet.
4. Contraindication for both spinal and general anaesthesia
5. Catheterised or self catheterising
6. Predicted life expectancy less than 3 years
7. Participation in any other current interventional trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Clinical effectiveness of treatments measured using change in international prostate symptom score (I-PSS) from baseline to 12 months post-intervention<br><br>Primary economic outcome measure:<br>2. Cost-effectiveness of treatments measured using incremental cost per quality-adjusted life year (QALY) gained at 12 months post-intervention.<br>2.1. Cost-effectiveness acceptability curves (CEACs) to assess the probability of each of the interventions being considered cost-effective at different willingness-to-pay (WTP) thresholds for a gained QALY<br>2.2. QALYs will be calculated using responses to the EQ-5D-5L questionnaire<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath